Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03394079 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT03394079 · ClinicalTrials.gov record · last posted 2026-01-02

Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention

Study acronym: OCTIVUS
StatusActive, Not Recruiting
PhaseNot applicable
Started2018-04-12
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The primary aim of this study is to compare the clinical efficacy and safety of OCT-guided(optical coherence tomography (OCT)-guided) and IVUS-guided(Intravascular ultrasound (IVUS)-guided) strategies in patients undergoing Percutaneous coronary intervention (PCI) with contemporary drug-eluting stents (DES) or drug-coated balloons (only for in-stent restenosis) for significant obstructive Coronary artery disease (CAD). The investigators hypothesize that OCT-guided PCI is non-inferior to IVUS-guided PCI with respect to primary end point of target-vessel failure (cardiac death, target-vessel myocardial infarction \[MI\], or ischemia-driven target-vessel revascularization \[TVR\]) at 1 year after randomization.

Amendment record 15 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 15 times since 2018-01-03; most recent amendment 2025-12-28. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-01-16
Status change Recruiting→Active, Not Recruitingv9
2018-05-09
Status change Not Yet Recruiting→Recruitingv3
Trial Details
NCT Number NCT03394079
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions Coronary Vessels
Enrollment 2,008 participants
Start Date 2018-04-12
Primary Completion 2023-02-17 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-02